Genital Diseases clinical trials
The registry lists 13 studies for Genital Diseases across more than 10 countries. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-27. Counting its 98 narrower conditions too, such as Prostatic Neoplasms: 30,997 studies, 5,890 open.
Get an email when these change. Save the Genital Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Steba Biotech S.A. (2) · FutureChem (1) · University of Alicante (1) · Qurasense (1) · Astellas Pharma Global Development, Inc. (1) · Sarah Schlegel (1) · Bayer (1) · Bagcilar Training and Research Hospital (1)
What is being tested here
Drugs under test in Genital Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Nov 2026Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions · Sarah Schlegel
- Nov 2026Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer. · University of Alicante
- Dec 2026Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer · Qurasense
- Sep 2027Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer · Astellas Pharma Global Development, Inc.
Who these studies take
Of the 8 Genital Diseases studies recruiting now, 6 (75%) set no upper age limit and 2 (25%) stop at 75 or younger. 0 (0%) take children under 18. 4 (50%) are for women only and 3 (38%) for men only; 4 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (38%) | 2 (25%) |
| 30 | 5 (63%) | 3 (38%) |
| 40 | 5 (63%) | 3 (38%) |
| 50 | 4 (50%) | 4 (50%) |
| 65 | 3 (38%) | 4 (50%) |
| 75 | 3 (38%) | 4 (50%) |
| 85 | 3 (38%) | 4 (50%) |
Across all 13 studies, recruiting or not: 23% stop at 75 or younger and 23% at 65; 0% take children; 38% are for women only and 54% for men only; 31% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 13 of 13. search them.
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 14 countries
- A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate CancerRecruitingNCT07853209Phase 31 country
- Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI TrialNot yet recruitingNCT07742553Phase 2/31 country
- Evaluation of the Q-Pad hrHPV Test System for Identifying PrecancerRecruitingNCT07281599Not applicable1 country
- Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital ConditionsRecruitingNCT06989593Not applicable1 country
- Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.RecruitingNCT07572760Not applicable1 country
- Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical CancerRecruitingNCT06815939Not applicable1 country
- Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerRecruitingNCT06463028Phase 21 country
- Correlation of Clitoral Hood and Labia Minora Measurements and Female Genital Self Image Scale (FGSIS) Scores in WomenRecruitingNCT061345961 country
- Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]CompletedNCT03555422Phase 310 countries
- Safety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerCompletedNCT00946881Phase 1/21 country
- Study of WST11 in Patients With Localized Prostate CancerCompletedNCT00707356Phase 23 countries
- Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic HyperplasiaCompletedNCT00657839Phase 21 country